| Valerie A Holst, MD | |
|
190 E Bannock St, Boise, ID 83712-6241 | |
| (208) 381-2367 | |
| Not Available |
| Full Name | Valerie A Holst |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 30 Years |
| Location | 190 E Bannock St, Boise, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861446064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | M8019 (Idaho) | Primary |
| 207ZC0500X | Pathology - Cytopathology | M8019 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Alphonsus Medical Center - Nampa | Nampa, ID | Hospital |
| West Valley Medical Center | Caldwell, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diagnostic Pathology Services Inc | 2567406689 | 5 |
News Archive
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Children and young adult burn survivors are more troubled by staring, bullying, and uncomfortable questions than the actual physical discomfort and memories of their accidents, according to research that was selected to be presented at the American Burn Association's Annual Meeting and published in the Journal of Burn Care & Research.
For adults, memories tend to fade with time. But a new study has shown that there are circumstances under which the opposite is true for small children: they can remember a piece of information better days later than they can on the day they first learned it.
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
› Verified 2 days ago
| Entity Name | Idaho Gastroenterology Associates, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265427256 PECOS PAC ID: 6002708773 Enrollment ID: O20040326001143 |
News Archive
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Children and young adult burn survivors are more troubled by staring, bullying, and uncomfortable questions than the actual physical discomfort and memories of their accidents, according to research that was selected to be presented at the American Burn Association's Annual Meeting and published in the Journal of Burn Care & Research.
For adults, memories tend to fade with time. But a new study has shown that there are circumstances under which the opposite is true for small children: they can remember a piece of information better days later than they can on the day they first learned it.
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
› Verified 2 days ago
| Entity Name | Diagnostic Pathology Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720014087 PECOS PAC ID: 2567406689 Enrollment ID: O20050620000122 |
News Archive
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Children and young adult burn survivors are more troubled by staring, bullying, and uncomfortable questions than the actual physical discomfort and memories of their accidents, according to research that was selected to be presented at the American Burn Association's Annual Meeting and published in the Journal of Burn Care & Research.
For adults, memories tend to fade with time. But a new study has shown that there are circumstances under which the opposite is true for small children: they can remember a piece of information better days later than they can on the day they first learned it.
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
› Verified 2 days ago
| Entity Name | Boise Pathology Group P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063466225 PECOS PAC ID: 7113943291 Enrollment ID: O20051018000831 |
News Archive
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Children and young adult burn survivors are more troubled by staring, bullying, and uncomfortable questions than the actual physical discomfort and memories of their accidents, according to research that was selected to be presented at the American Burn Association's Annual Meeting and published in the Journal of Burn Care & Research.
For adults, memories tend to fade with time. But a new study has shown that there are circumstances under which the opposite is true for small children: they can remember a piece of information better days later than they can on the day they first learned it.
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
› Verified 2 days ago
| Entity Name | Digestive Health Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750498333 PECOS PAC ID: 7315948874 Enrollment ID: O20070125000398 |
News Archive
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Children and young adult burn survivors are more troubled by staring, bullying, and uncomfortable questions than the actual physical discomfort and memories of their accidents, according to research that was selected to be presented at the American Burn Association's Annual Meeting and published in the Journal of Burn Care & Research.
For adults, memories tend to fade with time. But a new study has shown that there are circumstances under which the opposite is true for small children: they can remember a piece of information better days later than they can on the day they first learned it.
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valerie A Holst, MD Po Box 9589, Boise, ID 83707-4589 Ph: (208) 472-8104 | Valerie A Holst, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2367 |
News Archive
Transgender care is swiftly evolving, and primary care providers face a greater need to be clear about their roles and when to seek the support of specialists, according to the latest review by Mount Sinai experts in the field of transgender medicine.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Children and young adult burn survivors are more troubled by staring, bullying, and uncomfortable questions than the actual physical discomfort and memories of their accidents, according to research that was selected to be presented at the American Burn Association's Annual Meeting and published in the Journal of Burn Care & Research.
For adults, memories tend to fade with time. But a new study has shown that there are circumstances under which the opposite is true for small children: they can remember a piece of information better days later than they can on the day they first learned it.
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.
› Verified 2 days ago
Jack C Chaffin Jr., MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2152 | |
Elizabeth M Williams, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-3078 | |
Mark E Kieckbusch, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2367 Fax: 208-381-4762 | |
Nancy C Kois, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2152 | |
Daniel J Walsh, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2367 | |
Dr. Karen Ann Johnson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2378 | |
Edward J Kim, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2152 |